If you have been reading about phase 2 trial and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-09-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.
Retatrutide is a synthetic peptide developed as a single molecule that activates three distinct hormone receptors: GLP-1, GIP, and glucagon. The compound carries the internal designation LY3437943 and was engineered by modifying the backbone of glucose-dependent insulinotropic polypeptide. Its sequence incorporates non-natural amino acids and a fatty acid side chain that extends circulation time. The triple-agonist design aims to combine appetite suppression, improved insulin response, and increased energy expenditure in one agent. Published reports describe it as an investigational product rather than an approved medicine.
Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.
Retatrutide is an investigational peptide studied for obesity and type 2 diabetes. It is a single synthetic molecule designed to activate three metabolic receptors simultaneously. The compound belongs to the incretin mimetic family, a group of peptides that imitate gut hormones involved in appetite and glucose control. Its research code is LY3437943, and it remains under clinical study rather than cleared for routine medical use.
Acting as a triple agonist, the molecule binds the GLP-1, GIP, and glucagon receptors. GLP-1 activity slows gastric emptying and dampens appetite, while GIP signaling contributes to insulin sensitivity and fat metabolism. Glucagon receptor engagement raises energy expenditure and encourages fat breakdown, although it can also elevate blood glucose. Combining three pathways is intended to yield larger weight reduction than single or dual agonists, and researchers continue to examine how the balance among them shapes tolerability.
Clinical studies have reported notable reductions in body weight among participants. Early trials measured safety and explored several dose levels, and later studies tracked body-weight change over months of treatment. Investigators also monitor effects on glycemic markers, liver fat, and blood lipids. Because the compound is still in development, questions about long-term safety, cardiovascular outcomes, and durability after treatment ends remain open.
| Property | Value | Notes |
|---|---|---|
| Molecule class | Synthetic peptide | Engineered triple receptor agonist |
| Molecular weight | Approximately 4731 Da | Reported value; depends on form |
| Receptor targets | GLP-1, GIP, glucagon | Simultaneous activation |
| Development code | LY3437943 | Internal company designation |
| Current status | Investigational | No approved indication reported |
Pharmacologically the compound activates three receptors: GLP-1, GIP, and glucagon. GLP-1 and GIP signaling contribute to glucose-dependent insulin release, delayed gastric emptying, and reduced appetite, while glucagon receptor activation is associated with increased energy expenditure and hepatic fat oxidation. The single-molecule design is intended to keep these activities in one peptide rather than combining separate agents. Relative activity at each receptor differs, and the balance between them is a central question in interpretation. The glucagon component is partly offset by incretin-mediated insulin secretion, an interaction that remains incompletely characterized.
Development has progressed from single- and multiple-ascending-dose studies in healthy volunteers into larger randomized trials in adults with obesity, type 2 diabetes, and fatty liver disease. Early reports describe dose-dependent reductions in body weight and improvements in glycemic markers over treatment periods of several months. Whether the glucagon arm adds tolerability cost without added benefit is still debated. Long-term cardiovascular outcomes, effects after treatment stops, and performance in older or comorbid populations are open questions rather than settled findings. Approval status may change, so the current investigational label should be confirmed against regulatory sources.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
与仅靶向单一受体的同类药物相比，瑞他鲁肽增加胰高血糖素受体成分，理论上可提高能量消耗并改变脂肪分布。临床中观察到的体重变化是否主要来自该额外机制，目前尚无定论。胃肠道反应是该类药物常见不良事件，试验中通过剂量递增和监测进行管理。停药后体重反弹、个体差异和长期耐受性仍需更多数据。
瑞他鲁肽是一种在研合成肽，同时作用于胰高血糖素样肽-1、葡萄糖依赖性促胰岛素多肽和胰高血糖素受体。该分子属于多受体激动剂类别，尚未获得任何监管机构的上市批准。当前临床开发主要针对肥胖和2型糖尿病，研究代号为LY3437943。已确立的信息包括受体靶点和部分中期试验结果；最终疗效、长期安全性和适用人群仍属开放问题。
Peptides in this class degrade mainly through hydrolysis, oxidation, and aggregation. The lipid modification improves plasma residence time but can also promote self-association in aqueous solution at higher concentrations. Oxidation of methionine and deamidation of asparagine residues are common chemical liabilities that accumulate during storage. Stability studies therefore track purity loss, aggregate formation, and changes in receptor-binding potency over time under defined temperature and humidity conditions.
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
Retatrutide is an investigational synthetic peptide that acts on three receptor targets at once: glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon. It is developed by Eli Lilly and appears in the literature and in trial registries under the code LY3437943. The molecule belongs to a class of engineered peptides designed to resist rapid breakdown and permit infrequent subcutaneous administration. No regulatory agency has approved it for clinical use, and all available human data come from controlled trials rather than from routine practice.
== Applications == As a positron emitter, 64Cu has been used to produce experimental and clinical radiopharmaceuticals for the imaging of a range of conditions. Its beta emissions also raise the possibility of therapeutic applications. Compared to typical PET radionuclides it has a relatively long half-life, which can be advantageous for therapy, and for imaging certain physiological processes.
Popular protests broke out in early 2011, led by both secular and Islamist opposition groups. Longtime rebel groups like the Houthis and the Southern Movement also participated in the protests. Saleh responded with a violent crackdown, and the country nearly disintegrated into an all-out civil war as several army elements broke with the government and joined the protesters, beginning in March. Saleh was almost killed when a bomb went off in a mosque where he and other top government officials were praying on 3 June, apparently in an assassination attempt. While his condition initially appeared grave, Saleh recovered and returned to work on 23 September after several months of medical treatment in Saudi Arabia. He left Vice President Hadi in charge during his absence. As acting president, Hadi met with the opposition and reportedly expressed openness to political reforms. However, he rejected the idea of forcing Saleh from power without the president's consent.
=== Effects on cardiovascular system === Ghrelin has been theorized to have protective effects on the cardiovascular system. Studies have shown that in mice models of myocardial infarction (MI) with knock-outs of ghrelin, subjects with no endogenous ghrelin production had a significantly increased mortality rate along with worse metrics in terms of cardiac sympathetic activity and systolic function when compared to wild-type subjects. with exogenous ghrelin being shown to improve heart function in rodent models of chronic heart failure and improved ventricular remodeling in post-MI rats.
=== Medications === A variety of different types of medications can reduce symptoms of seborrhoeic dermatitis. These include certain antifungals, anti-inflammatory agents like corticosteroids and nonsteroidal anti-inflammatory drugs, antiandrogens, and antihistamines, among others. Treatments take into consideration potential side effects, including with long-term use given the chronic nature of seborrhoeic dermatitis. Initial therapy is usually a topical preparation with an agreeable side effect profile.
It would dictate US policy for the next twenty years. May 5–6: Peasants rebelled against the government in Cazin and in Velika Kladuša, Bosnia. The uprising was eventually suppressed by government forces. May 11: Robert Schuman describes his ambition of a united Europe. Known as the Schuman Declaration, it marks the beginning of the creation of the European Community. June 25: North Korea invades South Korea, beginning the Korean War. The United Nations Security Council votes to intervene to defend the South. The Soviet Union cannot veto, as it is boycotting the Security Council over the admission of People's Republic of China. June 28: North Korean forces capture Seoul. June 29: The first bombing attack on North Korea was approved by General Douglas MacArthur July 5: United Nations forces engage North Korean forces for the first time, in Osan. They fail to halt the North Korean advance, and fall southwards, towards what would become the Pusan Perimeter. September 30: United Nations forces land at Inchon. Defeating the North Korean forces, they press inland and re-capture Seoul. October 2: United Nations forces cross the 38th parallel, into North Korea. October 6: Forces from the People's Republic of China enter Tibet, with the goal of annexing the region into China itself. October 11: Stalin agrees to send MiG-15 fighters to provide air cover for Chinese forces moving into North Korea. October 22: Pyongyang, the capital of North Korea, falls to United Nations forces. October 22: China intervenes in Korea with 300,000 soldiers, catching the United Nations by surprise.
Sources: en.wikipedia.org
A sperm bank, semen bank, or cryobank is a facility that purchases, stores, and sells human semen. The semen is produced and sold by men who are known as sperm donors. The sperm is purchased by other persons for the purpose of achieving a pregnancy other than by a sexual partner. Sperm sold by a sperm donor is known as donor sperm. A sperm bank may be a separate entity supplying donor sperm to individuals or to fertility clinics, or it may be a facility which is run by a clinic for their customers. A pregnancy may be achieved using donor sperm for insemination with similar outcomes to sexual intercourse. By using sperm from a donor rather than from the sperm recipient's partner, the process is a form of third party reproduction. In the 21st century artificial insemination with donor sperm from a sperm bank is most commonly used for individuals with no male partner, such as single women and coupled lesbians. A sperm donor must generally meet specific requirements regarding age and screening for adverse medical history. In the United States, sperm banks are regulated as Human Cell and Tissue or Cell and Tissue Bank Product (HCT/Ps) establishments by the Food and Drug Administration. Many states in the U.S. also have regulations in addition to those imposed by the FDA. In the European Union a sperm bank must have a license, according to the EU Tissue Directive. In the United Kingdom, sperm banks are regulated by the Human Fertilisation and Embryology Authority.
It shares many similar causes, with the most common being chronic alcohol use, with other causes including recurrent acute episodes and cystic fibrosis. Abdominal pain, characteristically relieved by sitting forward or drinking alcohol, is the most common symptom. When the digestive function of the pancreas is severely affected, this may lead to problems with fat digestion and the development of steatorrhoea; when the endocrine function is affected, this may lead to diabetes. Chronic pancreatitis is investigated in a similar way to acute pancreatitis. In addition to management of pain and nausea, and management of any identified causes (which may include alcohol cessation), because of the digestive role of the pancreas, enzyme replacement may be needed to prevent malabsorption.
The group of Ernst Laqueur at the University of Amsterdam purified testosterone from bovine testicles in a similar manner in 1934, but the isolation of the hormone from animal tissues in amounts permitting serious study in humans was not feasible until three European pharmaceutical giants – Schering (Berlin, Germany), Organon (Oss, Netherlands) and Ciba – began full-scale steroid research and development programs in the 1930s. The Organon group in the Netherlands were the first to isolate the hormone, identified in a May 1935 paper "On Crystalline Male Hormone from Testicles (Testosterone)". They named the hormone testosterone, from the stems of testicle and sterol, and the suffix of ketone. The structure was worked out by Schering's Adolf Butenandt, at the Chemisches Institut of Technical University in Gdańsk. The chemical synthesis of testosterone from cholesterol was achieved in August that year by Butenandt and Hanisch. Only a week later, the Ciba group in Zurich, Leopold Ruzicka (1887–1976) and A. Wettstein, published their synthesis of testosterone. These independent partial syntheses of testosterone from a cholesterol base earned both Butenandt and Ruzicka the joint 1939 Nobel Prize in Chemistry. Testosterone was identified as 17β-hydroxyandrost-4-en-3-one (C19H28O2), a solid polycyclic alcohol with a hydroxyl group at the 17th carbon atom. This also made it obvious that additional modifications on the synthesized testosterone could be made, i.e., esterification and alkylation.
=== Legality of the strikes === Experts have questioned the legality of the strikes under US and international law. The US Coast Guard or other law enforcement agencies had been responsible for US drug interdiction efforts for decades prior to the strikes, and suspects were prosecuted as a criminal matter, but according to CNN, the DOJ argued before the strikes began "that the president is legally allowed to authorize lethal strikes against 24 cartels and criminal organizations in self-defense, because the groups pose an imminent threat to Americans". Experts speaking to the BBC said that the 2 September strike was potentially illegal under international maritime and human rights law. Though the US is not a signatory to the United Nations Convention on the Law of the Sea, previous US policy had been to "act in a manner consistent with its provisions"; countries are not supposed to interfere with ships in international waters except in cases such as hot pursuit out of a country's territorial waters.
Sources: en.wikipedia.org
Backed by the Kampuchean United Front for National Salvation, an organization of Khmer pro-Soviet Communists and Khmer Rouge defectors, Vietnam invaded Cambodia on 22 December 1978. The invasion succeeded in deposing Pol Pot, but the new state struggled to gain international recognition beyond the Soviet Bloc sphere. Despite the international outcry at the Pol Pot regime's gross human rights violations, representatives of the Khmer Rouge were allowed to be seated in the UN General Assembly, with strong support from China, the Western powers, and the member countries of ASEAN. Following the destruction of the Khmer Rouge, the national reconstruction of Cambodia was hampered, and Vietnam suffered a punitive Chinese attack. Although unable to deter Vietnam from ousting Pol Pot, China demonstrated that its Cold War communist adversary, the Soviet Union, was unable to protect its Vietnamese ally. Former U.S. Secretary of State Henry Kissinger wrote that "China succeeded in exposing the limits of...[Soviet] strategic reach" and speculated that the desire to "compensate for their ineffectuality" contributed to the Soviets' decision to intervene in Afghanistan a year later. In the 1973 oil crisis, Organization of Petroleum Exporting Countries (OPEC) cut their petroleum output. This raised oil prices and hurt Western economies, but helped the Soviet Union by generating a huge flow of money from its oil sales.
=== Dry foods === Dry food is a type of proprietary or artificially manufactured fish food consumed by a wide variety of tropical and saltwater fish and invertebrates. It is ideally suited to top dwellers and mid-water fish though numerous bottom dwelling species consume flake food once it has settled on the bottom. Flake food is baked to remove moisture, ensuring a longer shelf life. Generally the more moisture a particular example of fish food contains, the more readily it will deteriorate in quality. Dry foods are also available as pellets, sticks, flakes, tablets, granules, and wafers, manufactured to float or sink, depending on the species they are designed to feed.
The Jameson Raid (Afrikaans: Jameson-inval, lit. ''Jameson's Invasion'', 29 December 1895 – 2 January 1896) was a botched raid against the South African Republic (commonly known as the Transvaal) carried out by British colonial administrator Leander Starr Jameson, under the employment of Cecil Rhodes. It involved 500 British South Africa Company police and was launched from Rhodesia over the New Year weekend of 1895–96. Paul Kruger, for whom Rhodes had great personal hatred, was president of the South African Republic at the time. The raid was intended to trigger an uprising by the primarily British expatriate and settler workers (known as Uitlanders) in the Transvaal, but it failed. The workers were referred to as the Johannesburg Conspirators. They were expected to recruit an army and prepare for an insurrection; however, the raid was ineffective, and no uprising took place. The results included embarrassment of the British government; the replacement of Cecil Rhodes as prime minister of the Cape Colony; and the strengthening of Boer dominance of the Transvaal and its gold mines. Also, the withdrawal of so many fighting men left Rhodesia vulnerable, one factor that led just a couple of months later to the Second Matabele War. The raid was a contributory cause of the Second Boer War.
In an interview for Politico on 5 February, María Corina Machado indicated that elections could be held in Venezuela in 9 to 10 months, using manual voting. She said that she had not discussed about elections with Trump. National Assembly president and brother of Delcy, Jorge Rodríguez ruled out the possibility of elections in the near future in an interview for Newsmax. In an interview for NBC on 12 February, Delcy Rodríguez was asked if she will hold free and fair elections, she answered "absolutely" adding it will be decided as part of the "political dialogue." Also interviewed for the NBC, US Secretary of Energy Chris Wright, speaking from Caracas, said that elections could be held in the Venezuela before the end of second presidency of Donald Trump, and added about Machado that he "listened to her in a podcast a few days ago, she was asked that question: how fast can they hold elections in Venezuela? What do you think should happen, María? And she said to get it, probably the fastest it could be done it probably takes 9 to 10 months to get there. So I think she is realistic about what the changes that need to happen.
Solid phase microextraction, or SPME, is a solid-phase extraction sampling technique that involves the use of a fiber coated with an extracting phase, that can be a liquid (polymer) or a solid (sorbent), which extracts different kinds of analytes (including both volatile and non-volatile) from different kinds of media, that can be in liquid or gas phase. The quantity of analyte extracted by the fibre is proportional to its concentration in the sample as long as equilibrium is reached or, in case of short time pre-equilibrium, with help of convection or agitation.
Sources: en.wikipedia.org
Retatrutide is an investigational peptide that activates the GLP-1, GIP, and glucagon receptors at the same time. It is being studied for obesity and type 2 diabetes and has not been approved for clinical use. The internal code LY3437943 refers to the same molecule.
Most approved incretin therapies target one or two receptors, while retatrutide engages three. The addition of glucagon receptor activity is intended to raise energy expenditure. This broader mechanism is the subject of ongoing research rather than established practice.
No regulatory agency has approved retatrutide for any indication as of available public information. Development remains in later-stage trials. Availability claims found online should be treated as unverified.
It is a synthetic peptide classified as a triple receptor agonist. It engages the GLP-1, GIP, and glucagon receptors at once. It is investigated for metabolic and weight-related conditions rather than approved for general use.